Type 1 diabetes (T1D) is commonly diagnosed in childhood and the teen years. It’s a lifelong condition that requires treatment. Type 1 diabetes (T1D) is an autoimmune disease that occurs when the ...
Most patients with new-onset type 1 diabetes have substantial intact beta-cell reserve. 1 Thus, we analyzed the efficacy of semaglutide, an agonist of glucagon-like peptide 1 (GLP-1), in patients with ...
Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...
Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider ...
Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune ...
Nearly 4% of people in the US initially diagnosed with type 2 diabetes (T2D) between July 2016 and October 2024 were later reclassified as having type 1 diabetes (T1D), a new analysis of data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results